Konruns: There is no significant information that should be disclosed but has not been disclosed

On the evening of September 1st, Konruns Pharmaceuticals issued a stock trading anomaly announcement stating that, after self-examination and written inquiries with the controlling shareholder and actual controller, there are no significant undisclosed information that should be disclosed, apart from the matters already disclosed by the company